Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort.
Nasopharyngeal carcinoma
cisplatin
concomitant chemoradiotherapy
docetaxel
induction chemotherapy
Journal
Journal of chemotherapy (Florence, Italy)
ISSN: 1973-9478
Titre abrégé: J Chemother
Pays: England
ID NLM: 8907348
Informations de publication
Date de publication:
21 May 2023
21 May 2023
Historique:
medline:
22
5
2023
pubmed:
22
5
2023
entrez:
22
5
2023
Statut:
aheadofprint
Résumé
This is the report on our clinic's 15 years of experience (2004-2018) on nasopharyngeal carcinoma (NPC), treated with induction chemotherapy (IC) and subsequent concomitant chemoradiotherapy (CCRT), comprising population characteristics and treatment outcomes of 203 patients with non-metastatic NPC. IC comprised docetaxel (75 mg/m
Identifiants
pubmed: 37211862
doi: 10.1080/1120009X.2023.2215090
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM